In January of this year, the FDA noted that it had "received adverse event reports after patients used compounded semaglutide" and that "patients should not use a compounded drug if an approved drug is available to treat a patient." In July, the agency followed up with a notice that it had "received reports of adverse events, some requiring hospitalization, that may be related to overdoses due to dosing errors associated with compounded semaglutide injectable products." And in August, Eli Lilly, the maker of Zepbound and Mounjaro, sent a series of cease-and-desist letters to providers urging them to stop prescribing compounded versions of those drugs
Some patients find that adding electrolytes to their water helps, particularly if they experience diarrhea
The injection delivers a precise dose of the GLP-1 medication directly into your subcutaneous tissue, where its absorbed into your bloodstream
[1] [4] However, this can lead to inadequate intake of essential nutrients required for healthy hair growth, including protein, iron, zinc, and vitamins B12 and D